Search
for
Sort by
Research 421–450 of 1000+
- Finasteride-induced thrombocytopenia
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Pathogenetic justification of the use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.
- Is There Scientific Evidence that Panax Promotes Hair Growth?
- Finasteride in Androgenic Alopecia
- Unexpected Hair Regrowth Following Oral Bicalutamide Exposure in a Male Patient With Androgenetic Alopecia and a Suboptimal Response to Conventional Therapies: A Case Report
- Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review
- The Over‐The‐Counter Finasteride Alternative: A Critical Review of Saw Palmetto's Efficacy, Safety, and Regulatory Concerns
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- THERAPEUTIC EVALUATION OF ḤIJAMAH BIL SHART IN QILLAT SH'AR (ANDROGENETIC ALOPECIA): A CASE STUDY WITH UNANI AND BIOMEDICAL INSIGHTS
- AN OVERVIEW OF MEDICINAL PLANTS USED FOR THE TREATMENT OF HAIR LOSS
- Platelet-Rich Plasma in Androgenetic Alopecia: Is It Really Worth the Hype?
- Hair Loss Diagnosis and Treatment Knowledge Based System
- 5α‐Reductase Inhibitors
- Forum
- Finasteride bij vroege mannelijke kaalheid
- Neurosteroids and Epileptogenesis
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Propecia: The Goose That Lays the Golden Eggs
- Two Cases of Reversible Bilateral Painful Gynecomastia Induced by 1mg Oral Finasteride(Propecia$^{(R)})$
- The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
- Finasteride
- Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1
- Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia
- The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up
- The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism